Vaxcyte

Vaxcyte

PCVX· Manufacturing· Fiscal year ends in December

CEO pay in FY2024Stock +30.4% in FY2024

Grant E. Pickering is the CEO of Vaxcyte and was paid $39.6M in FY2024 (Dec).

Pay$100 in the stock at the end of FY20 → $235
CEO pay is from each Vaxcyte proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Executives5

See all
  1. 1Grant E. PickeringFY2024
  2. 2Andrew Guggenhime, M.B.A.FY2024
  3. 3Jim WassilFY2025
  4. 4Mikhail EydelmanFY2024
  5. 5Harp DhaliwalNot disclosed

Named executives and their total pay, from the Summary Compensation Table of the latest proxy.

Vaxcyte paid its one named executive on file $5.8M in FY2025 (Dec).

Name
Jim WassilExecutive Vice President and Chief Operating Officer
Grant E. PickeringChief Executive OfficerNot disclosedNot disclosed
Andrew Guggenhime, M.B.A.President and Chief Financial OfficerNot disclosed
Mikhail EydelmanSenior Vice President, General Counsel and Corporate SecretaryNot disclosed

of each named executive, from the Summary Compensation Table of each proxy.

Peers19

See all

The FY2024 (Dec) proxy of Vaxcyte names 19 peer companies for pay. Pay versus performance data of Vaxcyte for that year is not on file, so it has no rank.

The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year.

Board3

See all
  • Heath LukatchDirector · 7 yr on the boardIndependentCompensation—Paid as an executive
  • Halley GilbertDirector · 5 yr on the boardIndependentAudit, Nominating and Corporate Governance (Chair)—Paid as an executive
  • Olivier Brandicourt, M.D.Director · 0 yr on the boardIndependent—Paid as an executive

The board of the latest proxy (FY2025).

Shared directors

Activity

  1. PayDEF 14A
  2. Board3
  3. PayDEF 14A
  4. PayDEF 14A
  5. PayDEF 14A
  6. PayDEF 14A
  7. PayDEF 14A
  8. PayDEF 14A
  9. PayDEF 14A
  10. PayDEF 14A
  11. PayDEF 14A

Filings6

See all
Proxy statementDEF 14AApr 23, 2026FY2025
Annual report10-KFeb 24, 2026FY2025
Proxy statementDEF 14AApr 28, 2025FY2024
Annual report10-KFeb 25, 2025FY2024
Proxy statementDEF 14AApr 15, 2024FY2023
Annual report10-KFeb 27, 2024FY2023